ORIC Pharmaceuticals Statistics
Total Valuation
ORIC has a market cap or net worth of $620.62 million. The enterprise value is $303.84 million.
Market Cap | 620.62M |
Enterprise Value | 303.84M |
Important Dates
The last earnings date was Monday, May 6, 2024, after market close.
Earnings Date | May 6, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
ORIC has 67.42 million shares outstanding. The number of shares has increased by 49.37% in one year.
Shares Outstanding | 67.42M |
Shares Change (YoY) | +49.37% |
Shares Change (QoQ) | +17.07% |
Owned by Insiders (%) | 9.55% |
Owned by Institutions (%) | 95.87% |
Float | 36.20M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 1.89 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 21.31, with zero debt.
Current Ratio | 21.31 |
Quick Ratio | n/a |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -38.10% and return on invested capital (ROIC) is -34.72%.
Return on Equity (ROE) | -38.10% |
Return on Assets (ROA) | -34.80% |
Return on Capital (ROIC) | -34.72% |
Revenue Per Employee | n/a |
Profits Per Employee | -$997,676 |
Employee Count | 102 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +83.57% in the last 52 weeks. The beta is 1.18, so ORIC's price volatility has been higher than the market average.
Beta (1Y) | 1.18 |
52-Week Price Change | +83.57% |
50-Day Moving Average | 11.05 |
200-Day Moving Average | 9.28 |
Relative Strength Index (RSI) | 43.71 |
Average Volume (30 Days) | 568,529 |
Short Selling Information
The latest short interest is 10.24 million, so 15.19% of the outstanding shares have been sold short.
Short Interest | 10.24M |
Short Previous Month | 9.42M |
Short % of Shares Out | 15.19% |
Short % of Float | 28.29% |
Short Ratio (days to cover) | 20.57 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -114.09M |
Pretax Income | -101.76M |
Net Income | -101.76M |
EBITDA | -100.72M |
EBIT | -101.76M |
Earnings Per Share (EPS) | -$1.81 |
Balance Sheet
The company has $316.78 million in cash and no debt, giving a net cash position of $316.78 million or $4.70 per share.
Cash & Cash Equivalents | 316.78M |
Total Debt | n/a |
Net Cash | 316.78M |
Net Cash Per Share | $4.70 |
Equity / Book Value | 328.65M |
Book Value Per Share | 4.87 |
Working Capital | 308.87M |
Cash Flow
In the last 12 months, operating cash flow was -$95.25 million and capital expenditures -$757,000, giving a free cash flow of -$96.00 million.
Operating Cash Flow | -95.25M |
Capital Expenditures | -757,000 |
Free Cash Flow | -96.00M |
FCF Per Share | -$1.43 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
ORIC does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -49.37% |
Shareholder Yield | -49.37% |
Earnings Yield | -16.40% |
FCF Yield | -15.47% |
Analyst Forecast
The average price target for ORIC is $20.29, which is 121.51% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $20.29 |
Price Target Difference | 121.51% |
Analyst Consensus | Strong Buy |
Analyst Count | 8 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 2 |